Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, PR China.
Cancer Biother Radiopharm. 2012 Mar;27(2):119-23. doi: 10.1089/cbr.2011.1041. Epub 2011 Dec 8.
To explore the best time to carry out total body irradiation (TBI) in hematopoietic stem cell transplantation (HSCT) pretreatment.
Retrospective analysis was applied in 88 cases of HSCT using TBI as pretreatment from March 2001 to June 2009 in our hospital. Using 8 MV X-ray, all the patients were irradiated by linear accelerator in 2 consecutive days, with a total dose of 7-11 Gy and an instantaneous dose rate ranging between 4.0 and 5.0 cGy/min. Of the 88 cases, 40 cases were given traditional high-dose chemotherapy before TBI (Group CT/TBI), and 48 cases were given TBI before chemotherapy (Group TBI/CT) instead.
Eighty-seven cases of transplantation were successful, with no serious complications, including radiation pneumonia. Compared with Group CT/TBI, Group TBI/CT showed similar incidence of complications (p=0.08), similar recent chemotherapy toxicity (p=0.833), and significantly lower recent radiation toxicity (p=0.000).
TBI in the pretreatment of HSCT is safe and effective. Using TBI before the high-dose chemotherapy can maintain the same pretreatment effect, effectively reduce apparent immediate reaction/discomfort during TBI, reduce preparation workload of radiotherapy, and lower radiation side-effects. Further research is needed to expand its clinical application.
探讨造血干细胞移植(HSCT)预处理中全身照射(TBI)的最佳时机。
回顾性分析 2001 年 3 月至 2009 年 6 月我院 88 例行 TBI 预处理的 HSCT 患者的临床资料。采用 8MVX 射线,直线加速器连续 2 天进行照射,总剂量 7-11Gy,瞬时剂量率 4.0-5.0cGy/min。88 例患者中,40 例行 TBI 前传统大剂量化疗(CT/TBI 组),48 例行化疗前 TBI(TBI/CT 组)。
87 例移植均成功,无严重并发症,包括放射性肺炎。与 CT/TBI 组相比,TBI/CT 组并发症发生率相似(p=0.08),近期化疗毒性相似(p=0.833),近期放射毒性明显降低(p=0.000)。
HSCT 预处理中的 TBI 安全有效。在大剂量化疗前进行 TBI 可以保持相同的预处理效果,有效降低 TBI 期间的明显即刻反应/不适,减少放疗准备工作量,降低放射副作用。需要进一步研究以扩大其临床应用。